EDM logo

Author Centre

How to submit

Authors are required to complete our article template and submit online through the ScholarOne Manuscripts site.  Submissions are assessed by the Editorial Board and are subject to peer review by experts in the field.

Papers must be written in clear, concise UK or US English. Where English is not the author's first language, the paper should be checked by a native English speaker before submission (or a number of language editing services are available).


Appeals

Authors who feel they have grounds to appeal a rejection decision should send a rebuttal letter to the editorial office, detailing the reasons for the appeal.  Rebuttals will be considered by both the Editor-in-Chief and the Editorial Board Member handling the paper.  Decisions on appeals are final.   


Scope

Endocrinology, Diabetes & Metabolism Case Reports publishes case reports on common and rare conditions in all areas of clinical endocrinology, diabetes and metabolism.

Articles should include clear learning points which readers can use to inform medical education or clinical practice. The types of cases of interest to Endocrinology, Diabetes & Metabolism Case Reports include:

  • Insight into disease pathogenesis or mechanism of therapy
  • Novel diagnostic procedure
  • Novel treatment
  • Unique/unexpected symptoms or presentations of a disease
  • New disease or syndrome: presentations/diagnosis/management
  • Unusual effects of medical treatment
  • Error in diagnosis/pitfalls and caveats

Articles reporting a single case to a case series will be considered.

Ethics

All authors must abide by the standards outlined in the ethical policy. Endocrinology, Diabetes & Metabolism Case Reports is a member of, and subscribes to the principles of the Committee on Publication Ethics (COPE). Bioscientifica is a member of CrossCheck (powered by iThenticate) and manuscript submissions will be screened against the CrossCheck database.

Patient consent and confidentiality

Where possible, identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs or pedigrees, unless the information is essential for scientific purposes.

The patient (or parent or guardian) must give written informed consent for publication by signing our consent form. Informed consent requires that an identifiable patient be shown the manuscript to be published. Case reports will not be published without explicit consent from the patient or guardian. If the patient is dead, the authors should seek permission from a relative as a matter of courtesy.

Declaration of interest and funding

Authors must either declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported; or fully declare any financial or other potential conflict of interest.  Conflicts of interest include personal financial interests, employment and grants.

Authors must also detail all of the sources of funding relevant to the research reported.  Where research has not been funded a statement must be included to that effect.

License and copyright policy

Articles are published under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License (CC BY-NC-ND 3.0). Authors retain copyright and are permitted to copy and redistribute their work within the terms of this license. Authors also grant Bioscientifica Ltd (the publisher) commercial rights.

Bioscientifica also allow publication of articles under the CC BY licence if it is a requirement of the funder, for example the Wellcome Trust. Please contact the editorial office upon submission if you require the CC BY licence.

Permissions

Authors are responsible for clearing all copyright permissions for any work reproduced in their articles and paying any permission fees.

Charges to authors

Endocrinology, Diabetes & Metabolism Case Reports is an online-only, open-access publication. Expenses incurred for online submission, peer review, production, online hosting, archiving and marketing are covered by a publishing fee. This publishing fee will only become payable upon acceptance of a manuscript and needs to be paid for an article to proceed to publication.

The publication fee is £399*, and is payable upon article acceptance.  Members of endorsing societies enjoy a special publication fee of just £319*.

Supplementary data exceeding the bounds of the manuscript may be submitted for online publication. There are no charges for colour figures or supplementary data.

A discount may be available to authors from developing countries, please contact the editorial office for details.

*VAT (Value Added Tax) will be added to transactions within the UK and Europe.

References

References should be cited in the text in numerical order, and listed in the reference list in the order they are cited in the text. Where there are more than ten authors, the first ten should be listed, followed by et al.

If a reference consists of only a web address it should not be included in the reference list but cited in the text, along with the date the page was accessed. Citations of abstracts that are not generally accessible is discouraged.

Any unpublished work (personal communications, manuscripts in preparation and submitted but not yet accepted for publication) must be referred to in the text and not listed in the references. Give the full list of authors, including their initials, and the date. For example:

  • (A Stone, J Brown & M R Smith 2010, unpublished observations)
  • (J Brown 2011, personal communication)

Articles accepted for publication but not yet published may be listed as "in press" in the reference list, using the current year as the publication year. If an "in press" article is available online then the Digital Object Identifier (DOI) should be included; otherwise a copy of the article should be submitted as a supplementary file for reviewing purposes.

If using EndNote please select the European Journal of Endocrinology style.


Patient's perspective

We welcome comments from the patient; their own description of their experience may help other patients or clinicians who are dealing with a similar problem.  If the patient would like to contribute we urge authors to provide guidance and to ensure they include only relevant personal details.  Patients may describe their symptoms, how any tests and treatments affected them, and how the problem is now.  The patient's perspective will be included in the published article at the discretion of the Editor.


Gene and protein nomenclature

Wherever possible, manuscripts must be prepared in accordance with approved gene nomenclature. If a more widely used symbol exists it can be used if the authors prefer, provided that the accepted symbol is stated when the gene/protein is first used.
  • In gene and protein symbols, substitute Greek letters with the corresponding roman letter, e.g. TGFBR2 not TGFßR2
  • Avoid hyphens unless they are part of the approved symbol, e.g. IGF1 not IGF-1.
  • Use arabic rather than roman numerals, e.g. BMPR2 not BMPRII.
  • Gene symbols should be in italics with all letters capitalised, e.g. SOX2.
  • Protein designations should be the same as the gene symbols but not italicised, e.g. SOX2.
  • Please use symbols approved by the HUGO Gene Nomenclature Committee (HGNC).

Tables

  • Tables should be concise.
  • Number tables in the order they are cited in the text.
  • Include a title; a single sentence at the head of the table.
  • Use footnotes to provide any additional explanatory material, cross-referenced to the column entries.
  • Give a short heading for each column.
  • Do not use internal horizontal or vertical lines, colour or shading.
  • Explain all abbreviations used in the table in the footnotes.

Figures

  • Number figures in the order they are cited in the text.
  • Include legends to all figures, giving the figure number, keys to any symbols used, the names of any statistical tests used and the probability levels used for comparisons.
  • Label figure sections as A, B etc in the top left-hand corner.
  • Do not enclose figures in boxes.
  • Indicate magnification by a scale bar in the bottom right-hand corner of the image and give the measurement in the legend.
  • Use the preferred symbols of closed and open circles, squares and triangles. Ensure that symbols are large enough to be read clearly when the figure is reduced for publication. 

No specific feature within an image may be enhanced, obscured, moved, removed, or introduced. The groupings of images from different parts of the same gel, or from different gels, fields or exposures must be made explicit by the arrangement of the figure (e.g. using dividing lines) and in the text of the figure legend. Adjustments of brightness, contrast, or colour balance are acceptable if and as long as they do not obscure or eliminate any information present in the original. Nonlinear adjustments (e.g. changes to gamma settings) must be disclosed in the figure legend. Adjustments should be applied to the entire image. Threshold manipulation, expansion or contraction of signal ranges and the altering of high signals should be avoided.

This policy is adopted from The Journal of Cell Biology.


Article Promotion

Where appropriate, published case reports are promoted to scientists and clinicians from all over the world to ensure maximum reach and visibility of our authors' work.

How we may promote your work:

  • Press releases for papers of high interest and broad appeal
  • Communications to members of multiple endorsing societies via multiple media
  • Bioscientifica's publishing portfolio is promoted at c.40 conferences a year and your case report may be picked to feature on our Themed Collection handouts
  • Bimonthly email newsletters, including topic collections, sent to authors, readers, editors, reviewers and anybody else with an interest in the journal
  • Summaries of selected papers feature as Hot Topics
  • Social Media coverage


Tips for promoting your own work

Get the most out of your published article by considering the following:

  • You will receive a link to your published article which you can send to colleagues who may be interested in your line of research
  • Add your article to the list of publications on your institution's webpages
  • Use of social media: tweet your article and mention @EDMCaseReports for a retweet. Link to the paper in work-related blogs and professional websites
  • Finally, remember that your work is published Open Access and is free to read by anyone that may be interested!


Kudos

Bioscientifica is working with Kudos to help our authors maximize the impact of their published work.

Kudos provides a free set of tools to help you explain your work in new ways and share it both within your networks, and more widely. You can measure the results of these actions and track the resulting increase in downloads, readership and, ultimately, citations.

Authors using Kudos sharing tools receive on average 19% more downloads for their articles than those who don't.

Kudos is free to use and only takes a few minutes of your time.

Any questions?

Please get in touch with the Editorial Office and we will be very pleased to help.